Similar Diseases
- Adenosarcoma
- Carcinosarcoma of the uterus
- Malignant vaginal mixed epithelial and mesenchymal tumor
- Carcinosarcoma of the cervix uteri
- Body of uterus carcinosarcoma
- Body of uterus primitive neuroectodermal tumor
- Vaginal rhabdomyosarcoma
- Fallopian tube carcinosarcoma
- Blastoma
- Body of uterus mixed neoplasm
Made by DATEXIS (Data Science and Text-based Information Systems) at Beuth University of Applied Sciences Berlin
Deep Learning Technology: Sebastian Arnold, Betty van Aken, Paul Grundmann, Felix A. Gers and Alexander Löser. Learning Contextualized Document Representations for Healthcare Answer Retrieval. The Web Conference 2020 (WWW'20)
Funded by The Federal Ministry for Economic Affairs and Energy; Grant: 01MD19013D, Smart-MD Project, Digital Technologies
Results for Query ‹ Adenosarcoma risk ›
Uterine adenosarcoma – Prognosis
The prognosis is determined primarily by the cancer stage. Most tumours are discovered at an early stage and have a good prognosis, especially when compared to uterine carcinosarcoma. Five year survival for stage I and stage III tumours is approximately 80% and 50% respectively.
Uterine adenosarcoma – Abstract
Uterine adenosarcoma, also adenosarcoma of the uterus, and Müllerian adenosarcoma of the uterus, is an uncommon form of cancer that arises from mesenchymal tissue of the uterus and has a benign glandular component.